These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6820201)

  • 1. Therapeutic monitoring of valproic acid.
    Schobben F; van der Kleijn E; Vree TB
    Ther Drug Monit; 1980; 2(1):61-71. PubMed ID: 6820201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state kinetics of valproic acid in epileptic patients.
    Bruni J; Wilder BJ; Willmore LJ; Perchalski RJ; Villarreal HJ
    Clin Pharmacol Ther; 1978 Sep; 24(3):324-32. PubMed ID: 357068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid. Review of a new antiepileptic drug.
    Bruni J; Wilder BJ
    Arch Neurol; 1979 Jul; 36(7):393-8. PubMed ID: 110294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Feb; 13(2):81-123. PubMed ID: 402258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate monotherapy in children.
    Murphy JV
    Am J Med; 1988 Jan; 84(1A):17-22. PubMed ID: 3146220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy.
    Löscher W; Nau H; Siemes H
    Epilepsia; 1988; 29(3):311-6. PubMed ID: 3131137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of metabolites of valproic acid in plasma of epileptic patients.
    Löscher W
    Epilepsia; 1981 Apr; 22(2):169-78. PubMed ID: 6781893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of steady-state concentrations of valproic acid as determined from single plasma concentrations after the first dose.
    May CA; Garnett WR
    Clin Pharm; 1983; 2(2):143-7. PubMed ID: 6411412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of valproate during maintenance therapy in epileptic children.
    Lundberg B; Nergårdh A; Boréus LO
    J Neurol; 1982; 228(2):133-41. PubMed ID: 6185649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.
    Mihaly GW; Vajda FJ; Miles JL; Louis WJ
    Eur J Clin Pharmacol; 1979 Aug; 16(1):23-9. PubMed ID: 387418
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation and washout kinetics of valproic acid and its active metabolites.
    Pollack GM; McHugh WB; Gengo FM; Ermer JC; Shen DD
    J Clin Pharmacol; 1986; 26(8):668-76. PubMed ID: 3098806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scope and use of valproate in epilepsy.
    Penry JK; Dean JC
    J Clin Psychiatry; 1989 Mar; 50 Suppl():17-22. PubMed ID: 2494154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of clobazam with conventional antiepileptics in children.
    Theis JG; Koren G; Daneman R; Sherwin AL; Menzano E; Cortez M; Hwang P
    J Child Neurol; 1997 Apr; 12(3):208-13. PubMed ID: 9130097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of valproic acid and metabolites in mouse plasma and brain following constant-rate application of the drug and its unsaturated metabolite with an osmotic delivery system.
    Nau H; Zierer R
    Biopharm Drug Dispos; 1982; 3(4):317-28. PubMed ID: 6819013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapy.
    Hoffmann F; von Unruh GE; Jancik BC
    Eur J Clin Pharmacol; 1981; 19(5):383-5. PubMed ID: 6786896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.